Behr, Jürgen <br/><br/>
Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.  [electronic resource] 

 -  BMC pulmonary medicine  Sep 2017 
 - 122 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1471-2466 
<br/><br/><label>Standard No.: </label>10.1186/s12890-017-0462-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alveolitis, Extrinsic Allergic--complications<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Connective Tissue Diseases--complications<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Lung--physiopathology<br/>Male<br/>Middle Aged<br/>Pulmonary Fibrosis--drug therapy<br/>Pyridones--administration & dosage<br/>Research Design<br/>Treatment Outcome<br/>Vital Capacity--drug effects<br/>Young Adult